Pre-TKI cytokine profiling predicts CP–CML outcome

Measuring levels of transforming growth factor-α and interleukin-6 may help identify patients with newly diagnosed chronic phase–chronic myeloid leukaemia at risk of a poor outcome from tyrosine kinase inhibitor therapy, research suggests.
Source: MedWire News - Category: Consumer Health News Tags: Chronic myeloid leukaemia Source Type: news